Patents Assigned to Chitogenics, Inc.
  • Publication number: 20100190743
    Abstract: Methods of treating a subject suffering from a disorder in a mucosal tissue, such as interstitial cystitis; cancer in a mucous membrane such as bladder or vaginal cancer; Crohn's disease; inflammatory bowel disease or colitis, by administering a medicament containing a sulfated chitinous polymer administered topically are described. Pharmaceutical compositions containing the sulfate chitinous polymer are also disclosed.
    Type: Application
    Filed: April 5, 2010
    Publication date: July 29, 2010
    Applicant: Chitogenics, Inc.
    Inventors: Agis Kydonieus, Clive Elson, Susan Elizabeth Henderson
  • Patent number: 7265097
    Abstract: The present invention provides methods and compositions for delivering a therapeutic agent across a membrane that has limited permeability for the therapeutic agent. The method includes delivering the therapeutic agent to the membrane in a composition which includes a sulphated chitinous polymer as a primary carrier.
    Type: Grant
    Filed: August 20, 2002
    Date of Patent: September 4, 2007
    Assignee: Chitogenics, Inc.
    Inventors: Agis Kydonieus, Clive Elson, Maya Thanou
  • Patent number: 7238678
    Abstract: The present invention relates to a method of inhibiting cellular and protein attachment to substrates by applying a composition containing an effective amount of adherent N,O-carboxymethylchitosan to a substrate with such that cellular and protein attachment are prevented or greatly reduced.
    Type: Grant
    Filed: April 11, 2005
    Date of Patent: July 3, 2007
    Assignee: Chitogenics, Inc.
    Inventors: Clive Elson, Timothy D. G. Lee
  • Publication number: 20050214255
    Abstract: The invention pertains to N-acetylated, N, O-carboxyalkylchitosans and methods for using the chitosans to treat disorders, such as cancer, nervous system disorders, urinary tract disorders, and reproductive tract disorders.
    Type: Application
    Filed: March 25, 2004
    Publication date: September 29, 2005
    Applicant: CHITOGENICS, INC.
    Inventors: Clive Elson, Agis Kydonieus, Susan Henderson
  • Patent number: 6894035
    Abstract: The present invention relates to a method of inhibiting cellular and protein attachment to substrates by applying a composition containing an effective amount of adherent N,O-carboxymethylchitosan to a substrate with such that cellular and protein attachment are prevented or greatly reduced.
    Type: Grant
    Filed: September 25, 2003
    Date of Patent: May 17, 2005
    Assignee: Chitogenics, Inc.
    Inventors: Clive Elson, Timothy D. G. Lee
  • Patent number: 6809085
    Abstract: The present invention relates to drug delivery devices for moist tissue, in particular mucosal tissue and tissue in the serous cavities, as well as a method of its use. The devices, which contain NOCC, are adherent to the mucosal tissue, allowing localized drug delivery. The devices are particularly useful in vaginal, buccal and ocular devices.
    Type: Grant
    Filed: July 6, 2000
    Date of Patent: October 26, 2004
    Assignee: Chitogenics, Inc.
    Inventors: Clive M. Elson, Agis Kydonieus
  • Publication number: 20040132691
    Abstract: The present invention relates to a method of inhibiting cellular and protein attachment to substrates by applying a composition containing an effective amount of adherent N,O-carboxymethylchitosan to a substrate with such that cellular and protein attachment are prevented or greatly reduced.
    Type: Application
    Filed: September 25, 2003
    Publication date: July 8, 2004
    Applicant: CHITOGENICS, INC.
    Inventors: Clive Elson, Timothy D.G. Lee
  • Patent number: 6645947
    Abstract: The present invention relates to a method of inhibiting cellular and protein attachment to substrates by applying a composition containing an effective amount of adherent N,O-carboxymethylchitosan to a substrate with such that cellular and protein attachment are prevented or greatly reduced.
    Type: Grant
    Filed: May 20, 1999
    Date of Patent: November 11, 2003
    Assignee: Chitogenics, Inc.
    Inventors: Clive M. Elson, Timothy D. G. Lee
  • Patent number: 6124273
    Abstract: This invention is directed to the preparation and utilization of supplemented chitin hydrogels, such as chitosan hydrogels. Further provided are biomaterials comprising same. The particular supplement delivered by the chitin hydrogel is selected as a function of its intended use. In one embodiment, this invention provides a composition of matter, comprising a chitin hydrogel or chitin-derived hydrogel, wherein the hydrogel does not inhibit full-thickness skin wound healing.
    Type: Grant
    Filed: October 13, 1997
    Date of Patent: September 26, 2000
    Assignees: Chitogenics, Inc., The American National Red Cross, Coalition for Hemophilia B
    Inventors: William N. Drohan, Martin J. MacPhee, Shirley I. Miekka, Manish S. Singh, Clive Elson, John R. Taylor, Jr.
  • Patent number: 5888988
    Abstract: Covalent compositions of N,O-carboxymethyl chitosan (NOCC) are disclosed. NOCC can be intra- or intermolecularly linked, either through a direct bond or through a bridging moiety. Also disclosed are methods for preparing and using the covalent NOCC compositions. The NOCC compositions are useful in the administration of therapeutically active compounds and for wound management.
    Type: Grant
    Filed: May 6, 1997
    Date of Patent: March 30, 1999
    Assignee: Chitogenics, Inc.
    Inventor: Clive M. Elson
  • Patent number: 5679658
    Abstract: The invention relates to a method of treating patients to minimize post-surgical adhesions and a kit useful in the method of the invention. The method is based on the timing that N,O-carboxymethylchitosan (NOCC) has advantageous properties as a wound healing lavage and coating. A NOCC solution is particularly effective as a post-surgical lavage and when used in conjunction with a NOCC gel coating, wound healing rate is unchanged while the number and severity of adhesions in greatly reduced.
    Type: Grant
    Filed: May 8, 1995
    Date of Patent: October 21, 1997
    Assignee: Chitogenics, Inc.
    Inventor: Clive M. Elson
  • Patent number: 5645844
    Abstract: The present invention features a method and composition for attracting a target insect to a selected location. The invention is based on the discovery that negatively charged chitosan polymers, e.g., NOCC, have advantageous properties for use in a semiochemical delivery system for releasing a volatile semiochemical at a substantially sustained rate over an extended period of time to attract a target insect to a selected location. The present invention may be used for monitoring a target insect by capturing the insect. Alternatively, the present invention may be used for the management of a target insect by disrupting mating patterns of such insects.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 8, 1997
    Assignee: Chitogenics, Inc.
    Inventors: Susan Elizabeth Henderson, Dennis Thomas Curran, Clive M. Elson